Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Neonatal Point Of Care Testing Market Size, Value And Growth Trajectory Through 2030
The neonatal point of care testing market size has witnessed rapid expansion in recent years. This market is expected to grow from $1.32 billion in 2025 to $1.52 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 14.5%. The historical growth of this market can be attributed to factors like heightened awareness regarding neonatal mortality, the implementation of rapid testing devices in hospitals, government initiatives supporting neonatal care, the expansion of maternity clinics, and advancements in bedside testing technologies.
The neonatal point of care testing market size is projected for substantial expansion in the coming years. It is anticipated to reach $2.59 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 14.3%. This expansion during the forecast period is fueled by several factors, including the emergence of AI-based diagnostic tools, the integration of cloud technology for managing neonatal data, the availability of portable and compact point-of-care devices, a rise in private-public collaborations for newborn health, and the development of neonatal healthcare infrastructure in emerging economies. Key developments expected within this period encompass AI-enabled neonatal diagnostics, cloud-based point-of-care systems, mobile testing equipment, capabilities for real-time data analysis, and the incorporation of IoT for newborn monitoring.
Get A Free Sample Report With In-Depth Market Insights:
Neonatal Point Of Care Testing Market Growth Momentum: What Factors Are Shaping Demand?
The rising need for remote patient monitoring is anticipated to fuel the expansion of the neonatal point of care testing market in the future. Remote patient monitoring entails delivering medical care utilizing technology to link patients with healthcare experts remotely. The requirement for remote patient monitoring is growing because of the escalating need for easily accessible and convenient medical attention, particularly for individuals in distant or neglected regions. Neonatal point-of-care testing offers advantages to remote patient monitoring by delivering prompt bedside diagnostic outcomes, enabling healthcare professionals to swiftly detect and address urgent issues in newborns without depending on a centralized laboratory. As an illustration, in August 2023, as per Vivalink, a US-based healthcare technology company, a recent study indicated that 84% of current remote patient monitoring (RPM) users plan to increase their usage in 2024, 45% of healthcare providers are employing RPM for acute surveillance in hospital-at-home initiatives, and 77% are convinced that RPM-based care will surpass conventional inpatient hospital care within the next five years. Consequently, the escalating demand for remote patient monitoring is projected to stimulate the expansion of the neonatal point of care testing market.
Neonatal Point Of Care Testing Market Segment Analysis Spotlighting Growth Areas
The neonatal point of care testing market covered in this report is segmented –
1) By Product: Instruments, Assay
2) By Test Type: Neonatal Bilirubin Testing, Blood Glucose Testing, Infectious Disease Screening, Electrolyte Testing, Other Test Types
3) By End-Users: Hospitals, Maternity And Specialty Clinics, Other End-Users
Subsegments:
1) By Instruments: Blood Gas Analyzers, Bilirubinometers, Glucose Meters
2) By Assay: Bilirubin Assays, Glucose Assays, Infectious Disease Assays, Electrolyte Assays, Blood Gas Assays
Neonatal Point Of Care Testing Market Trends Redefining Industry Growth
Leading companies active in the neonatal point of care testing market are concentrating on establishing strategic collaborations to enable more efficient access to new markets and broader customer bases. Strategic collaborations are alliances where organizations merge resources and expertise to fulfill shared business objectives. For example, in January 2025, QIAGEN, a Netherlands-based provider of sample and assay technologies, collaborated with Genomics England, a UK-based genomic medicine company. This partnership has facilitated the launch of the Generation Study, designed to sequence the genomes of 100,000 newborns in England to screen for more than 200 actionable genetic conditions. QIAGEN will contribute unique clinically relevant variant information for the genes involved in the point-of-care sequencing test. This data will help in quicker interpretation and reporting of sequencing results, thus supporting earlier detection and treatment of rare conditions. The study, which officially began in October 2024, targets conditions that might affect approximately 3,000 newborns annually in the UK.
Neonatal Point Of Care Testing Market Competitive Landscape: Which Companies Lead The Industry?
Major companies operating in the neonatal point of care testing market are Abbott Laboratories, Siemens Healthineers AG, GE Healthcare Technologies Inc., Koninklijke Philips N.V., Roche Diagnostics International AG, Danaher Corporation, Dräger AG & Co. KGaA, Masimo Corporation, Radiometer Medical ApS, Nova Biomedical Corporation, bioMérieux SA, Sysmex Corporation, Nihon Kohden Corporation, Natus Medical Incorporated, Contec Medical Systems Co. Ltd., Edan Instruments Inc., Trivitron Healthcare, Bistos Co. Ltd., Bilimetrix S.r.l., GINEVRI Srl
View The Full Neonatal Point Of Care Testing Market Report:
Neonatal Point Of Care Testing Market Regional Breakdown: Where Is Demand Concentrated?
North America was the largest region in the neonatal point of care testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neonatal point of care testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
